サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：生体・生物医学材料の世界市場：種類別・材料別・用途別・地域別の評価、機会と予測 (2016年～2030年)
市場調査レポート
商品コード
1364043

生体・生物医学材料の世界市場：種類別・材料別・用途別・地域別の評価、機会と予測 (2016年～2030年)

Biological and Biomedical Materials Market Assessment, By Type, By Materials, By Application, By Region, Opportunities and Forecast, 2016-2030F
出版日: | 発行: Market Xcel - Markets and Data | ページ情報: 英文 144 Pages | 納期: 3～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.13円
生体・生物医学材料の世界市場：種類別・材料別・用途別・地域別の評価、機会と予測 (2016年～2030年)
出版日: 2023年10月17日
発行: Market Xcel - Markets and Data
ページ情報: 英文 144 Pages
納期: 3～5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の生体・生物医学材料の市場規模は、2022年に402億米ドルと評価され、予測期間中 (2023年～2030年) に10.7%のCAGRで成長し、2030年には907億米ドルに達すると予測されています。生物医学材料の発見は、複雑な手術を受けた患者の正常な機能を回復させ治癒を実現することで、現代の医療に革命をもたらしました。生体細胞、組織、金属、セラミックス、プラスチックは、希望通りの型・部品・繊維・フィルムに再加工することが可能で、生物医学製品・デバイスに徐々に使用されるようになりました。生物医学材料から作られたシーラントやパッチは、損傷した組織の再生と治癒を早めまする。糖尿病性潰瘍の患者は重度の感染症にかかりやすいですが、生体材料で治療することで、不必要な被覆材の交換を減らしながら治癒に導くことができます。

生物由来材料は一般に、動物・細菌・植物・真菌などの生物から生産され、生物細胞を増殖させる傷害治療に広く使用されています。世界保健機関 (WHO) が2022年7月に発表した最近の報告書によると、約19億1,000万人が筋骨格系障害に苦しんでいます。増大する問題は、外科的治療に組み込まれる生物医学材料に対する膨大な要求につながっています。最近の開発では、生体材料を使用した微細加工チップや、臓器チップ (organs-on-chip) の製造が進んでいます。

当レポートでは、世界の生体材料および生物医学材料の市場について分析し、製品の概略や市場の基本構造、全体的な市場規模の動向見通し、セグメント別・地域別の詳細動向、市場の背景事情や主な影響要因、主要企業のプロファイル・市場シェアなどを調査しております。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 新型コロナウイルス感染症 (COVID-19) が世界の生体・生物医学材料市場に与える影響

第4章 ロシア・ウクライナ戦争の影響

第5章 エグゼクティブサマリー

第6章 顧客側の見解

  • 市場認識と製品情報
  • ブランドの認知度とロイヤルティ
  • 購入意思決定時に考慮される要素
  • 購入頻度
  • 購入媒体

第7章 世界の生体・生物医学材料市場の将来展望 (2016年～2030年)

  • 市場規模と予測
    • 金額ベース
    • 数量ベース
  • 種類別
    • 生体材料
      • 微生物
      • 多糖類
      • ポリフェノール
      • その他
    • 生物医学材料
      • 自然
      • 合成
  • 材料別
    • 金属
    • セラミックス
    • ポリマー
    • その他
  • 用途別
    • 医療用インプラント
      • 膝関節置換術
      • ステント
      • ペースメーカー
      • 歯科インプラント
      • その他
    • 眼科
      • 緑内障
      • 眼科腫瘍
      • 前眼部手術
      • その他
    • 組織工学
    • バイオセンサー
    • 薬剤送達システム
      • 経皮送達
      • 眼内送達
      • 肺送達
      • その他
    • その他
  • 地域別
    • 北米
    • 欧州
    • 南米
    • アジア太平洋
    • 中東・アフリカ
  • 企業別市場シェア (%、2022年)

第8章 世界の生体・生物医学材料市場の将来展望：地域別 (2016年～2030年)

  • 北米*
    • 市場規模と予測
      • 金額ベース
      • 数量ベース
    • 種類別
    • 材料別
    • 用途別
    • 米国*
      • 市場規模と予測
      • 種類別
      • 材料別
      • 用途別
    • カナダ
    • メキシコ

各セグメントの情報は、対象となる全ての地域・国について提供されます。

  • 欧州
    • ドイツ
    • フランス
    • イタリア
    • 英国
    • ロシア
    • オランダ
    • スペイン
    • トルコ
    • ポーランド
  • 南米
    • ブラジル
    • アルゼンチン
  • アジア太平洋
    • インド
    • 中国
    • 日本
    • オーストラリア
    • ベトナム
    • 韓国
    • インドネシア
    • フィリピン
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • 南アフリカ

第9章 供給サイド分析

  • 生産能力：企業別
  • 生産量：企業別
  • 運用効率：企業別
  • 主要工場の所在地 (第25位まで)

第10章 市場マッピング (2022年)

  • 種類別
  • 材料別
  • 用途別
  • 地域別

第11章 マクロ環境と産業構造

  • 需給分析
  • 輸出入分析 (数量・金額ベース)
  • サプライ/バリューチェーン分析
  • PESTEL分析
    • 政治的要因
    • 経済システム
    • 社会的影響
    • 技術進歩
    • 環境への影響
    • 法令順守と規制方針 (法的機関を含む)
  • ポーターのファイブフォース分析
    • サプライヤーの交渉力
    • バイヤーの交渉力
    • 代替製品の脅威
    • 新規参入者の脅威
    • 競争企業間の敵対関係

第12章 市場力学

  • 成長促進要因
  • 成長抑制要因 (課題、制約)

第13章 主要企業の情勢

  • 市場リーダー上位5社：競合マトリックス
  • 市場リーダー上位5社：市場収益分析 (%、2022年)
  • 企業合併・買収 (M&A)/合弁事業 (該当する場合)
  • SWOT分析 (市場参入企業5社の場合)
  • 特許分析 (該当する場合)

第14章 価格分析

第15章 ケーススタディ

第16章 主要企業の見通し

  • Medtronic
    • 企業概要
    • 経営幹部
    • 製品・サービス
    • 財務状況 (報告どおり)
    • 重点市場と地理的プレゼンス
    • 最近の動向
  • Abbott
  • Johnson &Johnson
  • Philips
  • GE Healthcare
  • Becton Dickinson &Company
  • RevBio, Inc.
  • Aspect Biosystems Ltd.
  • Insomabio
  • Nurami Medical Nanofiber Technology

上記企業は市場シェア順ではなく、調査作業中に入手した情報に従って変更される可能性があります。

第17章 戦略提言

第18章 Market Xcelについて、免責事項

図表

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 2. Global Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 3. Global Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 4. Global Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 5. Global Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 6. Global Biological and Biomedical Materials Market Share, By Region, in USD Billion, 2016-2030F
  • Figure 7. North America Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 8. North America Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 9. North America Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 10. North America Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 11. North America Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 12. North America Biological and Biomedical Materials Market Share, By Country, in USD Billion, 2016-2030F
  • Figure 13. United States Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 14. United States Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 15. United States Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 16. United States Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 17. United States Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 18. Canada Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 19. Canada Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 20. Canada Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 21. Canada Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 22. Canada Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 23. Mexico Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 24. Mexico Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 25. Mexico Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 26. Mexico Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 27. Mexico Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 28. Europe Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 29. Europe Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 30. Europe Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 31. Europe Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 32. Europe Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 33. Europe Biological and Biomedical Materials Market Share, By Country, in USD Billion, 2016-2030F
  • Figure 34. Germany Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 35. Germany Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 36. Germany Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 37. Germany Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 38. Germany Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 39. France Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 40. France Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 41. France Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 42. France Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 43. France Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 44. Italy Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 45. Italy Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 46. Italy Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 47. Italy Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 48. Italy Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 49. United Kingdom Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 50. United Kingdom Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 51. United Kingdom Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 52. United Kingdom Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 53. United Kingdom Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 54. Russia Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 55. Russia Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 56. Russia Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 57. Russia Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 58. Russia Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 59. Netherlands Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 60. Netherlands Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 61. Netherlands Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 62. Netherlands Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 63. Netherlands Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 64. Spain Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 65. Spain Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 66. Spain Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 67. Spain Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 68. Spain Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 69. Turkey Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 70. Turkey Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 71. Turkey Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 72. Turkey Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 73. Turkey Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 74. Poland Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 75. Poland Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 76. Poland Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 77. Poland Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 78. Poland Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 79. South America Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 80. South America Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 81. South America Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 82. South America Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 83. South America Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 84. South America Biological and Biomedical Materials Market Share, By Country, in USD Billion, 2016-2030F
  • Figure 85. Brazil Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 86. Brazil Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 87. Brazil Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 88. Brazil Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 89. Brazil Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 90. Argentina Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 91. Argentina Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 92. Argentina Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 93. Argentina Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 94. Argentina Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 95. Asia-Pacific Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 96. Asia-Pacific Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 97. Asia-Pacific Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 98. Asia-Pacific Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 99. Asia-Pacific Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 100. Asia-Pacific Biological and Biomedical Materials Market Share, By Country, in USD Billion, 2016-2030F
  • Figure 101. India Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 102. India Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 103. India Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 104. India Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 105. India Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 106. China Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 107. China Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 108. China Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 109. China Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 110. China Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 111. Japan Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 112. Japan Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 113. Japan Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 114. Japan Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 115. Japan Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 116. Australia Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 117. Australia Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 118. Australia Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 119. Australia Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 120. Australia Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 121. Vietnam Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 122. Vietnam Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 123. Vietnam Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 124. Vietnam Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 125. Vietnam Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 126. South Korea Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 127. South Korea Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 128. South Korea Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 129. South Korea Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 130. South Korea Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 131. Indonesia Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 132. Indonesia Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 133. Indonesia Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 134. Indonesia Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 135. Indonesia Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 136. Philippines Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 137. Philippines Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 138. Philippines Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 139. Philippines Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 140. Philippines Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 141. Middle East & Africa Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 142. Middle East & Africa Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 143. Middle East & Africa Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 144. Middle East & Africa Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 145. Middle East & Africa Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 146. Middle East & Africa Biological and Biomedical Materials Market Share, By Country, in USD Billion, 2016-2030F
  • Figure 147. Saudi Arabia Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 148. Saudi Arabia Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 149. Saudi Arabia Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 150. Saudi Arabia Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 151. Saudi Arabia Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 152. UAE Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 153. UAE Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 154. UAE Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 155. UAE Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 156. UAE Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 157. South Africa Biological and Biomedical Materials Market, By Value, in USD Billion, 2016-2030F
  • Figure 158. South Africa Biological and Biomedical Materials Market, By Volume, in Kilotons, 2016-2030F
  • Figure 159. South Africa Biological and Biomedical Materials Market Share, By Type, in USD Billion, 2016-2030F
  • Figure 160. South Africa Biological and Biomedical Materials Market Share, By Materials, in USD Billion, 2016-2030F
  • Figure 161. South Africa Biological and Biomedical Materials Market Share, By Application, in USD Billion, 2016-2030F
  • Figure 162. By Type Map-Market Size (USD Billion) & Growth Rate (%), 2022
  • Figure 163. By Materials Map-Market Size (USD Billion) & Growth Rate (%), 2022
  • Figure 164. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2022
  • Figure 165. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2022
目次
Product Code: MX10526

Global biological and biomedical materials market size was valued at USD 40.2 billion in 2022, which is expected to reach USD 90.7 billion in 2030, with a CAGR of 10.7% for the forecast period between 2023 and 2030. The discovery of biomedical materials has revolutionized modern medicinal treatment by restoring normal functioning and achieving healing for patients after undergoing complex surgeries. Living cells, tissues, metals, ceramics, plastics can be reengineered into desired mold and parts, fibers, and films that are progressively used in biomedical products and devices. Sealants and patches made from biomedical materials allow damaged tissue to regenerate and heal faster. Patients with diabetic ulcers are prone to severe infections, which can be treated with biomaterials, leading to healing while reducing unnecessary dressing replacements.

Biologically derived materials are generally produced from biological organisms like animals, bacteria, plants, fungi where such materials are extensively used for injury treatment proliferating biological cells. A recent report published by the World Health Organization (WHO) in July 2022 stated that approximately 1.91 billion people are suffering from musculoskeletal disorders. The rising problems led to huge requirements for biomaterials incorporated into surgical treatments. A recent development is progressively moving towards producing microfabricated chips using biomaterials, organs-on-chip.

Innovative Biomedical Material on Drug Delivery Systems Augments the Market

Biomaterials are considered a prominent asset, significantly driving the advanced drug delivery systems to facilitate surgery, implantation, and treatment of serious oral diseases such as periodontitis, peri-implantitis, and severe dental problems. Natural polymeric substances such as calcium phosphate, chitosan, and gelatin are substantially used to prepare various drug delivery systems. Biomedical materials have significant characteristics like antibacterial and anti-inflammatory effects and are potentially active in enhancing antibiotic activities in oral infections. In addition to oral delivery, biomedical materials are successively creating avenues for drug delivery through transdermal, pulmonary, ocular, and nasal routes where specific designing of biomaterials accomplishes the desired delivery actions.

In November 2022, LTS Lohmann invested USD 14 million with the Global Health Investment Corporation. Along with the successive investment in June 2022, Evonik has partnered with the United States Government by investing USD 220 million to build innovative drug delivery system for new lipid production facility for mRNA-based therapies. The huge potential of Biological and Biomedical Materials in the drug delivery systems has impeccable market opportunities to expand with the rising health sector exponentially.

Regulations Adoption with Biological and Biomedical Materials Implementation

Numerous international and country-specific standards and guidelines have been framed to regulate utilizing biological and biomedical materials. Assuring effectiveness and enabling execution, some of the recognized institutions are International Organizations for Standard guidelines, ASTM International, United States Pharmacopeial Convention, and European Conformity Marking. Several standard tests and practices are being incorporated like testing of polymeric biological materials that are extensively used in surgical implants, assessment of selected tissue effects of absorbable biomaterials for implant with respect to muscle and bones.

Polymeric Biomedical Materials are Successively Incorporated in Medical Implants and Devices

Polymeric materials are recognized as remarkable due to their important characteristics such as flexibility, ease of fabrication, as well as biocompatible nature. Combined with other materials, composites of polymeric biomaterials deliver a wide range of electrical, mechanical, chemical, and thermal behaviors. Polyvinylidene fluoride (PVDF), which is a piezoelectric polymer material, is extensively used in biomedical applications as a pressure and flow sensors.

Solvay is one of the leading providers of biological materials with different specialty polymers for implantable medical devices. Numerous implantable fields like cardiovascular, spine, and orthopedics are progressively incorporating their proprietary Solviva biomaterials, including polysulfone, polyetheretherketone, etc., and Victrex Invibio's biocompatible PEEK-OPTIMA polymers are growing alternatives for spinal fusion devices. In May 2022, Solvay launched a new growth platform focusing on renewable materials and biotechnology.

Varied Applications in Medical Implants

The advancement in medical technology has consequently led to innovative medical implant materials varying from conventional silicone to 3D-printed biomaterials. Ultra-high molecular-weight polyethylene (UHMWPE) is progressively used in all kinds of knee replacements, along with hip replacement implants. Cross-linked polyethylene (XLPE) can successfully accomplish hip implants, removing the revision surgery requirement. 3D-printed implantable materials are gaining interest with a microfluidic approach that has prominently led to leaps in the vascularization of engineering tissues. In Australia, researchers have significantly developed a 3D printing Biopen device called Biosphere that essentially enable surgeons to repair damaged bones and cartilage by generating new cells directly.

A published report estimated that biomedical materials in cardiovascular devices are worth an annual USD 37.9 billion. FDA-approved vacuum plasma spray equipment for enhancing orthopedic implant capabilities Viant, a medical device design company in April 2021, has invested around USD 8 million. In September 2022, the State Council of China invested around USD 29 billion in advanced medical facilities to incorporate new biomedical materials.

Impact of COVID-19

The outbreak of COVID-19 had a devastating impact on mankind. Some developed countries, like the United States and the United Kingdom, with advanced-equipped healthcare systems, found it difficult to combat the virus. Biomaterials, an essential element for drug delivery systems emerged to develop antivirals. With diverse applications, the biomedical materials help in enhancing COVID-19 immunotherapeutics in developing preventive vaccines, treatments for infections, and healing and regeneration of damaged tissues. Moderna announced the investment of more capital in April 2021 to increase the global supply for COVID-19 vaccine to nearly about to 3 billion doses.

Impact of Russia-Ukraine War

The invasion of Russia on Ukraine has led to unprecedented impact on various sectors witnessing deterioration of global economy, including healthcare. A project named KOROVAI, was designed for the international community to aid Ukraine with the coordination of medical material gifting. The financial sanctions on Russia by the Western countries has led to severe outcomes on Russian health care facilities as Russia imports massive number of medical devices from the United States and European countries. These imperative factors severely impacted the applications of biomedical materials in treatments. The measures adopted by significant government agencies are expected to overcome the disaster of aggression and retain the economic instability.

Key Players Landscape and Outlook

The biomedical materials market is successfully growing due to various factors, like increasing healthcare expenditure, requiring numerous healthcare facilities, technological advancements, etc. Medtronic, a leading forefront of the medical industry, has developed excellent biomedical materials for treating various serious operations. Incorporating chitogel, which is a dissolvable biomaterial comprising a unique combination of natural ingredients, as a part of chitogel endoscopic sinus surgery kit. To optimize wound healing after sinus surgery, chitogel kit assists in minimizing adhesions, preserves structural integrity, and imperatively take care after surgery. In May 2023, Medtronic acquired EOFlow Co. Ltd., which manufactures tubeless, wearable, and completely disposable insulin delivery devices registered by EOPatch. The proprietary Medtronic's Meal Detection Technology algorithm will be utilized in the EOFlow diabatic device to enhance the treatment technology for diabetic patients.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Impact of COVID-19 on the Global Biological and Biomedical Materials Market

4. Impact of Russia-Ukraine War

5. Executive Summary

6. Voice of Customer

  • 6.1. Market Awareness and Product Information
  • 6.2. Brand Awareness and Loyalty
  • 6.3. Factors Considered in Purchase Decision
    • 6.3.1. Brand Name
    • 6.3.2. Quality
    • 6.3.3. Quantity
    • 6.3.4. Price
    • 6.3.5. Product Specification
    • 6.3.6. Application Specification
    • 6.3.7. Shelf-life
    • 6.3.8. Availability of Product
  • 6.4. Frequency of Purchase
  • 6.5. Medium of Purchase

7. Global Biological and Biomedical Materials Market Outlook, 2016-2030F

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
    • 7.1.2. By Volume
  • 7.2. By Type
    • 7.2.1. Biological
      • 7.2.1.1. Microorganisms
      • 7.2.1.2. Polysaccharides
      • 7.2.1.3. Polyphenols
      • 7.2.1.4. Others
    • 7.2.2. Biomedical
      • 7.2.2.1. Natural
      • 7.2.2.1.1. Protein-Based
      • 7.2.2.1.1.1. Gelatine
      • 7.2.2.1.1.2. Collagen
      • 7.2.2.1.1.3. Silk
      • 7.2.2.1.1.4. Fibrin
      • 7.2.2.1.2. Polysaccharide-Based
      • 7.2.2.1.2.1. Chitosan
      • 7.2.2.1.2.2. Alginate
      • 7.2.2.1.2.3. Cellulose
      • 7.2.2.2. Synthetic
      • 7.2.2.2.1. Polyurethane
      • 7.2.2.2.2. Polyethylene
      • 7.2.2.2.3. Alloys
      • 7.2.2.2.4. Others
  • 7.3. By Materials
    • 7.3.1. Metals
    • 7.3.2. Ceramics
    • 7.3.3. Polymers
    • 7.3.4. Others
  • 7.4. By Applications
    • 7.4.1. Medical Implants
      • 7.4.1.1. Knee Replacement
      • 7.4.1.2. Stent
      • 7.4.1.3. Pacemakers
      • 7.4.1.4. Dental Implants
      • 7.4.1.5. Others
    • 7.4.2. Ophthalmology
      • 7.4.2.1. Glaucoma
      • 7.4.2.2. Ocular Oncology
      • 7.4.2.3. Anterior Segment Surgery
      • 7.4.2.4. Others
    • 7.4.3. Tissues Engineering
    • 7.4.4. Biosensors
    • 7.4.5. Drug-delivery Systems
      • 7.4.5.1. Transdermal Delivery
      • 7.4.5.2. Ocular Delivery
      • 7.4.5.3. Pulmonary Delivery
      • 7.4.5.4. Others
    • 7.4.6. Others
  • 7.5. By Region
    • 7.5.1. North America
    • 7.5.2. Europe
    • 7.5.3. South America
    • 7.5.4. Asia-Pacific
    • 7.5.5. Middle East and Africa
  • 7.6. By Company Market Share (%), 2022

8. Global Biological and Biomedical Materials Market Outlook, By Region, 2016-2030F

  • 8.1. North America*
    • 8.1.1. Market Size & Forecast
      • 8.1.1.1. By Value
      • 8.1.1.2. By Volume
    • 8.1.2. By Type
      • 8.1.2.1. Biological
      • 8.1.2.1.1. Microorganisms
      • 8.1.2.1.2. Polysaccharides
      • 8.1.2.1.3. Polyphenols
      • 8.1.2.1.4. Others
      • 8.1.2.2. Biomedical
      • 8.1.2.2.1. Natural
      • 8.1.2.2.1.1. Protein-Based
      • 8.1.2.2.1.1.1. Gelatine
      • 8.1.2.2.1.1.2. Collagen
      • 8.1.2.2.1.1.3. Silk
      • 8.1.2.2.1.1.4. Fibrin
      • 8.1.2.2.1.2. Polysaccharide-Based
      • 8.1.2.2.1.2.1. Chitosan
      • 8.1.2.2.1.2.2. Alginate
      • 8.1.2.2.1.2.3. Cellulose
      • 8.1.2.2.2. Synthetic
      • 8.1.2.2.2.1. Polyurethane
      • 8.1.2.2.2.2. Polyethylene
      • 8.1.2.2.2.3. Alloys
      • 8.1.2.2.2.4. Others
    • 8.1.3. By Materials
      • 8.1.3.1. Metals
      • 8.1.3.2. Ceramics
      • 8.1.3.3. Polymers
      • 8.1.3.4. Others
    • 8.1.4. By Applications
      • 8.1.4.1. Medical Implants
      • 8.1.4.1.1. Knee Replacement
      • 8.1.4.1.2. Stent
      • 8.1.4.1.3. Pacemakers
      • 8.1.4.1.4. Dental Implants
      • 8.1.4.1.5. Others
      • 8.1.4.2. Ophthalmology
      • 8.1.4.2.1. Glaucoma
      • 8.1.4.2.2. Ocular Oncology
      • 8.1.4.2.3. Anterior Segment Surgery
      • 8.1.4.2.4. Others
      • 8.1.4.3. Tissues Engineering
      • 8.1.4.4. Biosensors
      • 8.1.4.5. Drug-delivery Systems
      • 8.1.4.5.1. Transdermal Delivery
      • 8.1.4.5.2. Ocular Delivery
      • 8.1.4.5.3. Pulmonary Delivery
      • 8.1.4.5.4. Others
      • 8.1.4.6. Others
    • 8.1.5. United States*
      • 8.1.5.1. Market Size & Forecast
      • 8.1.5.1.1. By Value
      • 8.1.5.1.2. By Volume
      • 8.1.5.2. By Type
      • 8.1.5.2.1. Biological
      • 8.1.5.2.1.1. Microorganisms
      • 8.1.5.2.1.2. Polysaccharides
      • 8.1.5.2.1.3. Polyphenols
      • 8.1.5.2.1.4. Others
      • 8.1.5.2.2. Biomedical
      • 8.1.5.2.2.1. Natural
      • 8.1.5.2.2.1.1. Protein-Based
      • 8.1.5.2.2.1.1.1. Gelatine
      • 8.1.5.2.2.1.1.2. Collagen
      • 8.1.5.2.2.1.1.3. Silk
      • 8.1.5.2.2.1.1.4. Fibrin
      • 8.1.5.2.2.1.2. Polysaccharide-Based
      • 8.1.5.2.2.1.2.1. Chitosan
      • 8.1.5.2.2.1.2.2. Alginate
      • 8.1.5.2.2.1.2.3. Cellulose
      • 8.1.5.2.2.2. Synthetic
      • 8.1.5.2.2.2.1. Polyurethane
      • 8.1.5.2.2.2.2. Polyethylene
      • 8.1.5.2.2.2.3. Alloys
      • 8.1.5.2.2.2.4. Others
      • 8.1.5.3. By Materials
      • 8.1.5.3.1. Metals
      • 8.1.5.3.2. Ceramics
      • 8.1.5.3.3. Polymers
      • 8.1.5.3.4. Others
      • 8.1.5.4. By Applications
      • 8.1.5.4.1. Medical Implants
      • 8.1.5.4.1.1. Knee Replacement
      • 8.1.5.4.1.2. Stent
      • 8.1.5.4.1.3. Pacemakers
      • 8.1.5.4.1.4. Dental Implants
      • 8.1.5.4.1.5. Others
      • 8.1.5.4.2. Ophthalmology
      • 8.1.5.4.2.1. Glaucoma
      • 8.1.5.4.2.2. Ocular Oncology
      • 8.1.5.4.2.3. Anterior Segment Surgery
      • 8.1.5.4.2.4. Others
      • 8.1.5.4.3. Tissues Engineering
      • 8.1.5.4.4. Biosensors
      • 8.1.5.4.5. Drug-delivery Systems
      • 8.1.5.4.5.1. Transdermal Delivery
      • 8.1.5.4.5.2. Ocular Delivery
      • 8.1.5.4.5.3. Pulmonary Delivery
      • 8.1.5.4.5.4. Others
      • 8.1.5.4.6. Others
    • 8.1.6. Canada
    • 8.1.7. Mexico

All segments will be provided for all regions and countries covered:

  • 8.2. Europe
    • 8.2.1. Germany
    • 8.2.2. France
    • 8.2.3. Italy
    • 8.2.4. United Kingdom
    • 8.2.5. Russia
    • 8.2.6. Netherlands
    • 8.2.7. Spain
    • 8.2.8. Turkey
    • 8.2.9. Poland
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
  • 8.4. Asia-Pacific
    • 8.4.1. India
    • 8.4.2. China
    • 8.4.3. Japan
    • 8.4.4. Australia
    • 8.4.5. Vietnam
    • 8.4.6. South Korea
    • 8.4.7. Indonesia
    • 8.4.8. Philippines
  • 8.5. Middle East & Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. South Africa

9. Supply Side Analysis

  • 9.1. Capacity, By Company
  • 9.2. Production, By Company
  • 9.3. Operating Efficiency, By Company
  • 9.4. Key Plant Locations (Up to 25)

10. Market Mapping, 2022

  • 10.1. By Types
  • 10.2. By Materials
  • 10.3. By Applications
  • 10.4. By Region

11. Macro Environment and Industry Structure

  • 11.1. Supply Demand Analysis
  • 11.2. Import Export Analysis - Volume and Value
  • 11.3. Supply/Value Chain Analysis
  • 11.4. PESTEL Analysis
    • 11.4.1. Political Factors
    • 11.4.2. Economic System
    • 11.4.3. Social Implications
    • 11.4.4. Technological Advancements
    • 11.4.5. Environmental Impacts
    • 11.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 11.5. Porter's Five Forces Analysis
    • 11.5.1. Supplier Power
    • 11.5.2. Buyer Power
    • 11.5.3. Substitution Threat
    • 11.5.4. Threat from New Entrant
    • 11.5.5. Competitive Rivalry

12. Market Dynamics

  • 12.1. Growth Drivers
  • 12.2. Growth Inhibitors (Challenges, Restraints)

13. Key Players Landscape

  • 13.1. Competition Matrix of Top Five Market Leaders
  • 13.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2022)
  • 13.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 13.4. SWOT Analysis (For Five Market Players)
  • 13.5. Patent Analysis (If Applicable)

14. Pricing Analysis

15. Case Studies

16. Key Players Outlook

  • 16.1. Medtronic
    • 16.1.1. Company Details
    • 16.1.2. Key Management Personnel
    • 16.1.3. Products & Services
    • 16.1.4. Financials (As reported)
    • 16.1.5. Key Market Focus & Geographical Presence
    • 16.1.6. Recent Developments
  • 16.2. Abbott
  • 16.3. Johnson & Johnson
  • 16.4. Philips
  • 16.5. GE Healthcare
  • 16.6. Becton Dickinson & Company
  • 16.7. RevBio, Inc.
  • 16.8. Aspect Biosystems Ltd.
  • 16.9. Insomabio
  • 16.10. Nurami Medical Nanofiber Technology

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

17. Strategic Recommendations

18. About Us & Disclaimer